HeyJaredKate Johnson
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Aug 26, 2026
Latest articles
Icotrokinra Shows Sustained Psoriasis Benefits at 1 Year (opens the original)
Read excerpt
One-year outcomes for icotrokinra (Icotyde, Johnson & Johnson), a targeted oral peptide that blocks the interleukin-23 (IL-23) receptor, showed durable skin clearance and symptom improvements in adults with moderate-to-severe plaque psoriasis. These results follow previously reported significantly higher response rates than placebo and deucravacitinib through weeks 16 and 24 in the phase III ICONIC-ADVANCE 1 and 2 trials. Icotrokinra was approved in March by the FDA for the treatment of moderate
Are Universal Digital Mental Health Interventions Effective? (opens the original)
Read excerpt
Universal digital mental health interventions (DMHIs) aimed at promoting well-being and resilience in children and youth are associated with small improvements in some psychological outcomes, although the overall certainty of evidence is low, according to a systematic review and meta-analysis. The study, which involved 16 meta-analyses across 57 studies and included 43,973 participants, found that hybrid interventions (which combined digital delivery with in-person engagement) had the most consi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.